Bank of America’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,296
| Closed | -$1K | – | 6700 |
|
|
2019
Q3 | $1K | Sell |
1,296
-1,310
| -50% | -$1.01K | ﹤0.01% | 6358 |
|
|
2019
Q2 | $2K | Buy |
2,606
+1,154
| +79% | +$886 | ﹤0.01% | 6190 |
|
|
2019
Q1 | $2K | Hold |
1,452
| – | – | ﹤0.01% | 6163 |
|
|
2018
Q4 | $1K | Sell |
1,452
-213
| -13% | -$147 | ﹤0.01% | 6257 |
|
|
2018
Q3 | $5K | Sell |
1,665
-10,857
| -87% | -$32.6K | ﹤0.01% | 6098 |
|
|
2018
Q2 | $46K | Buy |
12,522
+10,278
| +458% | +$37.8K | ﹤0.01% | 5465 |
|
|
2018
Q1 | $8K | Sell |
2,244
-1,019
| -31% | -$3.63K | ﹤0.01% | 5927 |
|
|
2017
Q4 | $10K | Sell |
3,263
-4,139
| -56% | -$12.7K | ﹤0.01% | 5794 |
|
|
2017
Q3 | $52K | Buy |
7,402
+305
| +4% | +$2.14K | ﹤0.01% | 5135 |
|
|
2017
Q2 | $66K | Sell |
7,097
-950
| -12% | -$8.84K | ﹤0.01% | 5025 |
|
|
2017
Q1 | $87K | Sell |
8,047
-703
| -8% | -$7.6K | ﹤0.01% | 4955 |
|
|
2016
Q4 | $74K | Buy |
+8,750
| New | +$74K | ﹤0.01% | 4994 |
|